Stock 4570 IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Immuno-Biological Laboratories Co., Ltd.

Equities

4570

JP3921300004

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-12 am EDT 		5-day change 1st Jan Change
522 JPY +1.36% Intraday chart for Immuno-Biological Laboratories Co., Ltd. +0.19% +5.88%
2023 Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2023 An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd. CI

Business Summary

Immuno-Biological Laboratories Co., Ltd. is a Japan-based company engaged in the research, development, manufacture and sales of pharmaceutical products and quasi-drugs. The Company operates in four business segments. The Diagnostic and Reagent segment is engaged in the manufacture, purchase and sales of research-related reagents, medicine, as well as vitro diagnostics. The Genetically Modified Silkworm segment is engaged in the sales of transgenic silkworm cocoons related products and research development of pharmaceutical raw materials. The Testing segment is engaged in the provision of support for prevention and diagnosis in addition to drug discovery and research support in the field of lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics segment is engaged in the sales of cosmetics and other products.

Number of employees: 57

Sales per Business

JPY in Million2023Weight2024Weight Delta
Antibody
99.5 %
791 99.5 % 813 99.5 % +2.81%
Cosmetics
0.5 %
4 0.5 % 4 0.5 % -4.23%

Sales per region

JPY in Million2023Weight2024Weight Delta
Japan
67.3 %
538 67.7 % 550 67.3 % +2.20%
United States
15.1 %
131 16.5 % 123 15.1 % -6.51%
Others
10.4 %
64 8.0 % 85 10.4 % +32.68%
China
7.3 %
-- 59 7.3 % -

Managers

Managers TitleAgeSince
Tsutomu Seito PSD
 President 79 82-08-31
Masato Nakagawa ADM
 Chief Administrative Officer 61 07-09-30
Masahiro Maeda BRD
 Director/Board Member 66 94-03-31
Shoko Onodera BRD
 Director/Board Member 63 85-03-31

Members of the board

Members of the board TitleAgeSince
Tsutomu Seito PSD
 President 79 82-08-31
Shoko Onodera BRD
 Director/Board Member 63 85-03-31
Masahiro Maeda BRD
 Director/Board Member 66 94-03-31
Masato Nakagawa ADM
 Chief Administrative Officer 61 07-09-30
Kenji Fukunaga BRD
 Director/Board Member 54 10-05-31
Ikkei Kojima BRD
 Director/Board Member 41 19-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 9,314,590 7,494,658 ( 80.46 %) 1,132 ( 0.0122 %) 80.46 %

Shareholders

NameEquities%Valuation
Tsutomu Seito
12.06 %
1,123,700 12.06 % 4 M ¥
Rahim Barati
2.255 %
210,000 2.255 % 695 822 ¥
TRANS GENIC INC.
2.201 %
205,000 2.201 % 679 255 ¥
Akira Hoshikawa
1.621 %
151,000 1.621 % 500 329 ¥
Kazumi Nakazawa
1.091 %
101,600 1.091 % 336 646 ¥
THE TOWA BANK, LTD.
1.074 %
100,000 1.074 % 331 344 ¥
Shoko Onodera
0.5368 %
50,000 0.5368 % 165 672 ¥
Masahiro Maeda
0.1589 %
14,800 0.1589 % 49 039 ¥
Masato Nakagawa
0.1041 %
9,700 0.1041 % 32 140 ¥
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
0.0118 %
1,100 0.0118 % 3 645 ¥

Holdings

NameEquities%Valuation
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
0.01%
 1,100 0.01% 3,645 $

Company contact information

Immuno-Biological Laboratories Co., Ltd.

1091-1 Naka Aza-Higashida

375-0005, Fujioka

+

http://www.ibl-japan.co.jp
address Immuno-Biological Laboratories Co., Ltd.(4570)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. Stock Immuno-Biological Laboratories Co., Ltd.
+5.88% 30.79M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.66% 247B
NOVARTIS AG Stock Novartis AG
+17.90% 228B
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
PFIZER, INC. Stock Pfizer, Inc.
+0.45% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4570 Stock
  4. Company Immuno-Biological Laboratories Co., Ltd.